The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells.
about
An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situHeparanase deglycanation of syndecan-1 is required for binding of the epithelial-restricted prosecretory mitogen lacritin.The Tiam1 PDZ domain couples to Syndecan1 and promotes cell-matrix adhesionHeparan Sulfate Proteoglycans May Promote or Inhibit Cancer Progression by Interacting with Integrins and Affecting Cell MigrationSyndecan-1 in Cancer: Implications for Cell Signaling, Differentiation, and PrognosticationMolecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicineSyndecans play dual roles as cell adhesion receptors and docking receptorsHeparan sulfate proteoglycans in the control of B cell development and the pathogenesis of multiple myelomaWhy the stroma matters in breast cancer: insights into breast cancer patient outcomes through the examination of stromal biomarkersTumor specific liposomes improve detection of pancreatic adenocarcinoma in vivo using optoacoustic tomographySpecific syndecan-1 domains regulate mesenchymal tumor cell adhesion, motility and migrationInhibitory activity of YKL-40 in mammary epithelial cell differentiation and polarization induced by lactogenic hormones: a role in mammary tissue involutionMMP7 shedding of syndecan-1 facilitates re-epithelialization by affecting alpha(2)beta(1) integrin activationCrystal Structure of N -Glycosylated Human Glypican-1 Core ProteinSyndecan-1 and Its Expanding List of ContactsInsights into the key roles of proteoglycans in breast cancer biology and translational medicineNeuronal Thy-1 induces astrocyte adhesion by engaging syndecan-4 in a cooperative interaction with alphavbeta3 integrin that activates PKCalpha and RhoABinding of laminin-1 to monosialoganglioside GM1 in lipid rafts is crucial for neurite outgrowthFibroblast EXT1-levels influence tumor cell proliferation and migration in composite spheroidsComparative genomics of the syndecans defines an ancestral genomic context associated with matrilins in vertebratesMechanisms of heparanase inhibitors in cancer therapy.Orthotopic pancreatic tumors detected by optoacoustic tomography using Syndecan-1.Transmembrane and extracellular domains of syndecan-1 have distinct functions in regulating lung epithelial migration and adhesion.Display of cell surface sites for fibronectin assembly is modulated by cell adherence to (1)F3 and C-terminal modules of fibronectinHeparanase alters arterial structure, mechanics, and repair following endovascular stenting in mice.Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis.Interaction of syndecan and alpha6beta4 integrin cytoplasmic domains: regulation of ErbB2-mediated integrin activation.Matrix regulators in neural stem cell functions.Angiomodulin, a marker of cancer vasculature, is upregulated by vascular endothelial growth factor and increases vascular permeability as a ligand of integrin αvβ3Syndecan-1 is required to maintain intradermal fat and prevent cold stress.Syndecan-1 knock-down in decidualized human endometrial stromal cells leads to significant changes in cytokine and angiogenic factor expression patterns.Syndecan-1 in breast cancer stroma fibroblasts regulates extracellular matrix fiber organization and carcinoma cell motility.Maturation of dendritic cells depends on proteolytic cleavage by cathepsin X.Shed syndecan-1 translocates to the nucleus of cells delivering growth factors and inhibiting histone acetylation: a novel mechanism of tumor-host cross-talk.Heparan sulfate proteoglycans.Targeting tumor cell motility to prevent metastasis.Tumor-derived syndecan-1 mediates distal cross-talk with bone that enhances osteoclastogenesis.Syndecan-2 is a novel ligand for the protein tyrosine phosphatase receptor CD148Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumorsLaminin Peptide-Immobilized Hydrogels Modulate Valve Endothelial Cell Hemostatic Regulation.
P2860
Q21195234-E8A5DB2C-6ADA-4C69-91BD-538873BCA2B5Q24303785-2EB2843A-6782-4BE3-A2AE-75EAC15E7BB5Q24305474-D18E8852-82DD-4F07-B555-6CA45EA74820Q26777586-338760AC-2334-411A-BBEF-E4F0ADD9FA05Q26784262-7F274953-18AE-4FDE-9837-9FD5AE8CE3B0Q26796247-4161AD8F-0A5C-45BE-A3CE-127609BC00A7Q27000634-B7F1B018-B345-4EAB-B4D3-CE9A056EB35EQ27001749-89A9B330-C2B8-4735-915D-FD2A3FB0F37EQ27023385-9EE8303F-BA78-412B-B198-711C753684DDQ27304350-7DE49958-BFF5-4AA3-9DF1-637CC2CE57BEQ27313760-DAE40D59-904D-4AEC-A905-97537568A588Q27317208-59B2DAA1-101C-4D25-9F3A-A0B2D5B6333DQ27345120-7F9A3299-1360-4CEB-ABA1-3137D17BC2FDQ27677391-DC287975-4CCC-4301-8F8B-5965949B0012Q28084514-DDC290CE-D5F2-4E76-B3D5-4EF4C7F0E30EQ28085548-8FD2E70C-BC75-431B-8C4D-C90360B23927Q28567226-24DD6C2E-DD54-457E-824B-F041D80D04E2Q28575929-C3B2751D-379C-4D55-B9C7-D463B5B4FCB2Q28728778-AFB38846-FC9F-41FD-9907-58BA5C1330F0Q28768923-FAD5D256-F7BE-4011-969E-E4180D010C4EQ30244089-7CC717B3-E252-465D-8D6E-1A45B79D4954Q30394919-F493B084-A401-4B5E-A101-B058014AF3E8Q30525661-C4660CA8-799D-4CD6-B28C-62CAB5A3F010Q33396940-11324469-6734-4760-B106-642AA62F256FQ33585394-B3B89943-08DE-4E91-B0EF-E9550B9FD0A1Q33754644-1C1DBFE0-734D-4A20-9EA6-60EED85F617DQ33809991-6969BEF1-F89A-4B37-AE1A-A28B47A0CBB4Q33819268-F974D0B9-70B9-43C1-8F3E-FF1FBD424CD0Q33913526-505C44E9-4C45-4710-97FA-0FB5410A3DE4Q34015240-FE6F680B-DABB-4700-B714-EFF034699BAAQ34335807-26DFD92C-6068-4903-A2D6-01D0C90BE3ADQ34756068-A51C2861-E5F6-43D7-BAEE-C8FF7EC2113DQ34808420-985F6453-3970-4721-A392-CC34947BE51DQ34958906-7D1F58D5-B973-445E-89BF-AAF6FE666F1EQ35059448-95AA08A9-3CEC-435D-ABF3-A560FC3CEF79Q35095152-04432B5C-753E-4EA0-A5B4-D8FB2680D9CAQ35140763-5AD9B528-075F-4E5D-806E-4A2FFC9E2B03Q35241542-44FDC40C-CEE7-45F6-8AEB-CAC210830C0AQ35650530-FFFF374E-7624-46CB-ACBA-9ECE9DC5A912Q35668536-3035A7E7-7573-4C0F-A4F0-EC0615AEC053
P2860
The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
The syndecan-1 ectodomain regu ...... human mammary carcinoma cells.
@ast
The syndecan-1 ectodomain regu ...... human mammary carcinoma cells.
@en
type
label
The syndecan-1 ectodomain regu ...... human mammary carcinoma cells.
@ast
The syndecan-1 ectodomain regu ...... human mammary carcinoma cells.
@en
prefLabel
The syndecan-1 ectodomain regu ...... human mammary carcinoma cells.
@ast
The syndecan-1 ectodomain regu ...... human mammary carcinoma cells.
@en
P2093
P2860
P356
P1476
The syndecan-1 ectodomain regu ...... human mammary carcinoma cells.
@en
P2093
Alan C Rapraeger
Brandon J Burbach
DeannaLee M Beauvais
P2860
P304
P356
10.1083/JCB.200404171
P407
P577
2004-10-01T00:00:00Z